Despite this well-established genetic association, the precise molecular mechanisms by which ASXL1 mutations contribute to BOS pathogenesis remain poorly understood, warranting further investigation into its role in brain development and its contribution to the clinical features of BOS. Here, ASXL1 is linked to Buschke-Ollendorff syndrome.